Patent - Abbreviated New Drug Application Cases filed in the Fourth Circuit Courts
Celgene Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00003
Plaintiff: Celgene Corporation
Defendant: Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan, N.V.
Cause Of Action: 35 U.S.C. § 145
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2019cv00203
Plaintiff: Astrazeneca Pharmaceuticals LP and AstraZeneca AB
Defendant: mylan inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Mylan N.V. et al We have downloadable decisions or orders for this case
as 1:2017cv00181
Plaintiff: Sanofi-Aventis U.S. LLC , Sanofi-Aventis Deutschland GMBH and Sanofi Winthrop Industrie
Defendant: Mylan N.V. , Mylan GMBH , Mylan Inc. and others
Counter_claimant: Mylan Inc. , Mylan N.V. , Mylan Pharmaceuticals Inc. and others
Counter_defendant: Sanofi Winthrop Industrie , Sanofi-Aventis Deutschland GMBH and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 145
Indivior Inc. et al v. Mylan Technologies Inc. et al
as 1:2017cv00157
Plaintiff: Indivior Inc. and Indivior UK Limited
Defendant: Mylan Technologies Inc., Mylan Pharmaceuticals Inc. and Mylan N.V.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?